Sirona Announces Board Departures

Long Island City, New York, Jan 18, 2012 – Sirona (Nasdaq: SIRO – News), a dental record leader, currently announced that Nicholas W. Alexos and Timothy D. Sheehan will step down from a Board of Directors effective Jan 18, 2012.  Mr. Alexos and Mr. Sheehan have served on a house given Jun 2006 and both were members of Sirona Holdings Luxco S.C.A. (“Luxco”), a investment organisation that acquired Sirona in 2005.  After their departure, a combination of a house will be 6 eccentric directors and 3 members of a Sirona government team. 

“On interest of the whole Board, I

Article source:

Aribex Invests in H2O TECH to Develop Breakthrough Dental Technology


Aribex, Inc., a worldwide personality in handheld cat-scan technologies and
manufacturer of a NOMAD® Pro Handheld X-ray System, today
announced it has done an investment in H2O TECH, Inc. This is a first
time Aribex has invested in an outward company. Details of the
transaction were not disclosed; however, Aribex officials have confirmed
Aribex will have a chair on H2O TECH’s

Article source:

Dental mentor is all smiles after honour

Published on Thursday 12 Jan 2012 09:01

A BARNFIELD College mentor has been awarded an MBE in a New Year’s Honours List in approval of her grant to dental nursing.

Angie McBain, lead dental nurse

Article source:

Cascade Medical Enterprises, LLC Announces a Sale of Their Orthopedic Business

WAYNE, N.J. , Jan. 6, 2012 /PRNewswire/ — Cascade Medical Enterprises, LLC (CME), a heading association with exclusive platelet-rich plasma (PRP) and platelet-rich fibrin pattern (PRFM) record for use in orthopedic healing applications in soothing hankie and bone repair, announced a sale of their record to Musculoskeletal Transplant Foundation (MTF) and placement by ConMed Linvatec for a worldwide orthopedic, dental, and wound caring markets.

CME has had a prolonged collaborative US placement attribute with MTF for a sale of their products in a sports medicine market.  This partnership has enabled a companies to grasp a infirm marketplace participation establishing

Article source:

#1: ATSU announces new dental school

A day of good news
A.T. Still University faculty, staff and students, village members, supervision officials and some-more swarming into a press discussion Feb. 17, anticipating to hear good news after several months of anticipating to attract ATSU’s new dental propagandize plan to Kirksville. A grassroots bid lifted $1.1 million in internal funding, and many people sat nervously with a awaiting of a vital mercantile growth event looming.
They were not disappointed.

“The A.T. Still University Board of Trustees unanimously supports bringing a bend of ATSU’s Arizona School of Dentistry and Oral Health to a University’s Kirksville campus,” ATSU house chairman

Article source:

Dental patients prepared to pointer adult during new Thurso clinic

A THURSO village councillor this week welcomed a news that a £1.2 million dental hospital during a Dunbar Hospital will open on Jan 11.

“It has been a prolonged time entrance though this is something that should be welcomed with open arms,” pronounced village legislature authority Don Smith.

He pronounced a trickery will capacitate people to get NHS dental diagnosis in a city rather than carrying to go to Wick, Golspie or even serve afield.

“It is positively indispensable here and we wish there will be adequate places for everybody who needs a trickery as private dental diagnosis is really expensive. It is

Article source:

Sirona to Present during a 30th Annual J.P. Morgan Healthcare Conference in San Francisco on Jan 10th 2012

LONG ISLAND CITY, N.Y. – Dec 21, 2011 — Sirona (Nasdaq: SIRO – News), a dental record leader, currently announced that Jost Fischer, Chairman and CEO, will benefaction during a 30th Annual J.P. Morgan Healthcare Conference  on Tuesday, Jan 10th, 2012 during a Westin St. Francis Hotel in San Francisco.

The display will be webcast live and accessible following a discussion during

About Sirona Dental Systems, Inc.

Sirona, a dental record leader, has served dealers and dentists worldwide for some-more than 130 years. Sirona develops, manufactures, and markets a finish line of dental products, including CAD/CAM replacement systems

Article source:

Sirona Ranked Among Top U.S. Companies by Institutional Investor Magazine’s 2012 Investor Relations Survey

Long Island City, New York, Dec 9, 2011 – Sirona (Nasdaq: SIRO – News), a dental record leader, currently announced that it was ranked among America`s tip companies according to Institutional Investor`s 2012 All-American Executive team, a publication`s annual Investor Relations survey.  John Sweeney, Vice President Investor Relations, was famous as a “IR Professional of a Year”, a tip financier family veteran in a United States.  In addition, John was nominated “Best Investor Relations Professional” in a Company`s attention zone by both a buy-side and sell-side.  Simone Blank, Executive Vice President and Chief Financial Officer, was ranked as one of

Article source:

BIOLASE Issued Broad New Patent for Treating Eye Conditions, Including Presbyopia, Cataracts and Glaucoma

IRVINE, CA–(Marketwire -11/30/11)- BIOLASE Technology, Inc. (NASDAQ: BLTI – News), a World’s heading dental laser manufacturer and distributor, currently announced that a U.S. Patent and Trademark Office has released BIOLASE a new obvious covering a use of a laser technologies for treating several conditions of a eye. The obvious covers a design and techniques for treating an visible or associated hankie site utilizing laser appetite to impact one or some-more physiological properties mitigating a effects of presbyopia and improving a approach a chairman sees.

Patent 8,056,564 is patrician “Methods for Treating Eye Conditions” and supports a ophthalmic patents previously

Article source:

BIOLASE to Present during Upcoming Investment Conferences

IRVINE, CA–(Marketwire -11/29/11)- BIOLASE Technology, Inc. (NASDAQ: BLTI – News), a World’s heading dental laser manufacturer and distributor, announced currently that government is scheduled to make financier presentations during dual arriving investment conferences.

The initial discussion will be CANACCORD Genuity’s 6th Annual Cardiovascular, Aesthetics Metabolic Disorders Conference on Tuesday, Dec 6, during that COO and CFO Fred Furry is scheduled to benefaction during 10:00 am Pacific Time. The one-day discussion is being hold during a St. Regis Hotel in San Francisco.

A live audio webcast of a display during a CANACCORD Genuity Conference will be accessible in

Article source: